Gut-Brain Cross-Talk in Metabolic Control
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Gut-Brain Cross-Talk in Metabolic Control. / Clemmensen, Christoffer; Müller, Timo D; Woods, Stephen C; Berthoud, Hans-Rudolf; Seeley, Randy J; Tschöp, Matthias H.
I: Cell, Bind 168, Nr. 5, 23.02.2017, s. 758-774.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Gut-Brain Cross-Talk in Metabolic Control
AU - Clemmensen, Christoffer
AU - Müller, Timo D
AU - Woods, Stephen C
AU - Berthoud, Hans-Rudolf
AU - Seeley, Randy J
AU - Tschöp, Matthias H
N1 - Copyright © 2017 Elsevier Inc. All rights reserved.
PY - 2017/2/23
Y1 - 2017/2/23
N2 - Because human energy metabolism evolved to favor adiposity over leanness, the availability of palatable, easily attainable, and calorically dense foods has led to unprecedented levels of obesity and its associated metabolic co-morbidities that appear resistant to traditional lifestyle interventions. However, recent progress identifying the molecular signaling pathways through which the brain and the gastrointestinal system communicate to govern energy homeostasis, combined with emerging insights on the molecular mechanisms underlying successful bariatric surgery, gives reason to be optimistic that novel precision medicines that mimic, enhance, and/or modulate gut-brain signaling can have unprecedented potential for stopping the obesity and type 2 diabetes pandemics.
AB - Because human energy metabolism evolved to favor adiposity over leanness, the availability of palatable, easily attainable, and calorically dense foods has led to unprecedented levels of obesity and its associated metabolic co-morbidities that appear resistant to traditional lifestyle interventions. However, recent progress identifying the molecular signaling pathways through which the brain and the gastrointestinal system communicate to govern energy homeostasis, combined with emerging insights on the molecular mechanisms underlying successful bariatric surgery, gives reason to be optimistic that novel precision medicines that mimic, enhance, and/or modulate gut-brain signaling can have unprecedented potential for stopping the obesity and type 2 diabetes pandemics.
KW - Animals
KW - Appetite Regulation
KW - Brain
KW - Energy Metabolism
KW - Gastrointestinal Tract
KW - Homeostasis
KW - Humans
KW - Neural Pathways
KW - Pleasure
KW - Satiation
KW - Journal Article
KW - Review
U2 - 10.1016/j.cell.2017.01.025
DO - 10.1016/j.cell.2017.01.025
M3 - Review
C2 - 28235194
VL - 168
SP - 758
EP - 774
JO - Cell
JF - Cell
SN - 0092-8674
IS - 5
ER -
ID: 186639734